These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Transforming growth factor-alpha expression is enhanced in human mammary epithelial cells transformed by an activated c-Ha-ras protooncogene but not by the c-neu protooncogene, and overexpression of the transforming growth factor-alpha complementary DNA leads to transformation. Ciardiello F; McGeady ML; Kim N; Basolo F; Hynes N; Langton BC; Yokozaki H; Saeki T; Elliott JW; Masui H Cell Growth Differ; 1990 Sep; 1(9):407-20. PubMed ID: 1981145 [TBL] [Abstract][Full Text] [Related]
8. Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells. Ichikawa T; Ichikawa Y; Isaacs JT Proc Natl Acad Sci U S A; 1992 Mar; 89(5):1607-10. PubMed ID: 1542651 [TBL] [Abstract][Full Text] [Related]
9. Induction by estrogen metabolite 16 alpha-hydroxyestrone of genotoxic damage and aberrant proliferation in mouse mammary epithelial cells. Telang NT; Suto A; Wong GY; Osborne MP; Bradlow HL J Natl Cancer Inst; 1992 Apr; 84(8):634-8. PubMed ID: 1556774 [TBL] [Abstract][Full Text] [Related]
10. Expression of the oncogenes mil and ras abolishes the in vivo differentiation of mammary epithelial cells. Günzburg WH; Salmons B; Schlaeffli A; Moritz-Legrand S; Jones W; Sarkar NH; Ullrich R Carcinogenesis; 1988 Oct; 9(10):1849-56. PubMed ID: 3048764 [TBL] [Abstract][Full Text] [Related]
11. Role of the Ha-ras (RasH) oncogene in mediating progression of the tumor cell phenotype (review). Boylan JF; Jackson J; Steiner MR; Shih TY; Duigou GJ; Roszman T; Fisher PB; Zimmer SG Anticancer Res; 1990; 10(3):717-24. PubMed ID: 2195986 [TBL] [Abstract][Full Text] [Related]
12. EJ/ras neoplastic transformation of simian virus 40-immortalized human uroepithelial cells: a rare event. Christian BJ; Kao CH; Wu SQ; Meisner LF; Reznikoff CA Cancer Res; 1990 Aug; 50(15):4779-86. PubMed ID: 2164447 [TBL] [Abstract][Full Text] [Related]
13. Transforming and oncogenic potential of activated c-Ha-ras in three immortalized human breast epithelial cell lines. Wang B; Soule HD; Miller FR Anticancer Res; 1997; 17(6D):4387-94. PubMed ID: 9494538 [TBL] [Abstract][Full Text] [Related]
14. Relationship between metastatic ability and H-ras oncogene expression in rat mammary cancer cells transfected with the v-H-ras oncogene. Kyprianou N; Isaacs JT Cancer Res; 1990 Mar; 50(5):1449-54. PubMed ID: 2105838 [TBL] [Abstract][Full Text] [Related]
18. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells. Su ZZ; Austin VN; Zimmer SG; Fisher PB Oncogene; 1993 May; 8(5):1211-9. PubMed ID: 8479744 [TBL] [Abstract][Full Text] [Related]
19. c-Ha-rasEJ transfection of rat aortic smooth muscle cells induces epidermal growth factor responsiveness and characteristics of a malignant phenotype. Sadhu DN; Lundberg MS; Burghardt RC; Ramos KS J Cell Physiol; 1994 Dec; 161(3):490-500. PubMed ID: 7962130 [TBL] [Abstract][Full Text] [Related]
20. Induction of transforming growth factor alpha expression in mouse mammary epithelial cells after transformation with a point-mutated c-Ha-ras protooncogene. Ciardiello F; Kim N; Hynes N; Jaggi R; Redmond S; Liscia DS; Sanfilippo B; Merlo G; Callahan R; Kidwell WR Mol Endocrinol; 1988 Dec; 2(12):1202-16. PubMed ID: 3063955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]